SELECT LANGUAGE BELOW

Pro-life supporters rejoice after Costco reveals new policy on abortion medication.

Pro-life supporters rejoice after Costco reveals new policy on abortion medication.

Costco’s Decision on Abortion Pill Draws Mixed Reactions

Following pressure from pro-life advocates, Costco has decided not to sell the abortion pill mifepristone in its pharmacies. Critics of the medication argue that its approval by the FDA back in 2000 was hasty, influenced more by politics than by healthcare considerations.

Mifepristone has become a popular alternative for those seeking abortions, reportedly being involved in about two-thirds of all abortions in the U.S. Its availability without the necessity of in-person physician approval has raised concerns among some groups.

In a statement, Costco emphasized that their choice to refrain from carrying mifepristone stems from a lack of demand from customers and clarification that such medications are generally prescribed by healthcare professionals. Costco operates around 500 pharmacies throughout the country.

The Family Research Council has applauded Costco’s stance. Mary Zoch, a representative from the group, expressed gratitude that Costco, known for serving families, has opted to remain a grocery store rather than enter the realm of abortion provision. She noted that families can shop there without the worry of contributing to, as she put it, “the murder of countless innocent fetuses.”

There are ongoing efforts from pro-life groups to extend similar initiatives against the sale of mifepristone at other major pharmacy chains like Walmart, CVS, and Walgreens. This comes amidst a regulatory environment where Walgreens plans to continue distributing mifepristone under FDA guidelines, despite the ongoing debates.

Interestingly, a study from the Center for Ethics and Public Policy raised alarms about potential adverse effects from mifepristone that appear to be more prevalent than the FDA has indicated. The report claims that over ten percent of users experienced severe medical issues, including sepsis and the need for surgeries.

The Supreme Court, earlier this year, chose not to impose a block on the sale of mifepristone, allowing the legal discussions around it to move forward.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News